Camber Capital Management as of March 31, 2015
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 36 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Spy Tr Unit Put Option (SPY) | 14.9 | $206M | 1.0M | 206.43 | |
| Teva Pharmaceutical Inds Adr (TEVA) | 7.4 | $103M | 1.7M | 62.30 | |
| Masimo Corporation (MASI) | 6.4 | $89M | 2.7M | 32.98 | |
| Medicines Company | 5.0 | $70M | 2.5M | 28.02 | |
| Genomic Health | 4.6 | $64M | 2.1M | 30.55 | |
| Express Scripts Holding | 4.4 | $61M | 700k | 86.77 | |
| Ariad Pharmaceuticals | 4.2 | $58M | 7.0M | 8.24 | |
| Universal American | 4.0 | $56M | 5.2M | 10.68 | |
| AMAG Pharmaceuticals | 4.0 | $56M | 1.0M | 54.66 | |
| Orthofix International Nv Com Stk | 3.9 | $54M | 1.5M | 35.89 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 3.6 | $50M | 400k | 126.09 | |
| Cyberonics | 3.5 | $49M | 750k | 64.92 | |
| Select Medical Holdings Corporation (SEM) | 3.2 | $45M | 3.0M | 14.83 | |
| Abbvie (ABBV) | 3.2 | $44M | 750k | 58.54 | |
| Keryx Biopharmaceuticals | 2.7 | $38M | 3.0M | 12.73 | |
| Bruker Corporation (BRKR) | 2.7 | $37M | 2.0M | 18.47 | |
| Kindred Healthcare | 2.6 | $36M | 1.5M | 23.79 | |
| Sequenom Com New | 2.6 | $36M | 9.0M | 3.95 | |
| CONMED Corporation (CNMD) | 2.4 | $34M | 671k | 50.49 | |
| Arena Pharmaceuticals | 2.4 | $33M | 7.5M | 4.37 | |
| Amarin Corp Spons Adr New (AMRN) | 2.0 | $28M | 12M | 2.34 | |
| GenMark Diagnostics | 1.4 | $19M | 1.5M | 12.98 | |
| Trevena | 1.3 | $19M | 2.9M | 6.52 | |
| Cross Country Healthcare (CCRN) | 1.2 | $17M | 1.4M | 11.86 | |
| Epirus Biopharmaceuticals In (EPRSQ) | 1.2 | $17M | 1.8M | 8.95 | |
| BioScrip | 1.0 | $13M | 3.0M | 4.43 | |
| AngioDynamics (ANGO) | 0.9 | $13M | 729k | 17.79 | |
| Allscripts Healthcare Solutions (MDRX) | 0.9 | $12M | 1.0M | 11.96 | |
| Protalix Biotherapeutics Note 4.500% 9/1 (Principal) | 0.5 | $6.9M | 9.0M | 0.77 | |
| Invitae (NVTAQ) | 0.5 | $6.7M | 400k | 16.76 | |
| OraSure Technologies (OSUR) | 0.4 | $5.7M | 864k | 6.54 | |
| Cardica | 0.4 | $5.3M | 8.4M | 0.63 | |
| Targacept | 0.3 | $4.6M | 1.6M | 2.97 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.3 | $3.6M | 2.0M | 1.78 | |
| Inovio Pharmaceuticals Com New | 0.1 | $2.0M | 250k | 8.16 | |
| Biolase Warrant | 0.0 | $309k | 7.4M | 0.04 |
